Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.800
-0.190 (-9.55%)
At close: May 8, 2026, 4:00 PM EDT
1.810
+0.010 (0.56%)
After-hours: May 8, 2026, 7:59 PM EDT
Palisade Bio Employees
Palisade Bio had 14 employees as of December 31, 2025. The number of employees increased by 6 or 75.00% compared to the previous year.
Employees
14
Change (1Y)
6
Growth (1Y)
75.00%
Revenue / Employee
n/a
Profits / Employee
-$1,198,643
Market Cap
301.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 14 | 6 | 75.00% |
| Dec 31, 2024 | 8 | -1 | -11.11% |
| Dec 31, 2023 | 9 | -3 | -25.00% |
| Dec 31, 2022 | 12 | -1 | -7.69% |
| Dec 31, 2021 | 13 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Artiva Biotherapeutics | 104 |
| Silence Therapeutics | 88 |
| Rezolute | 75 |
| Armata Pharmaceuticals | 60 |
| Immuneering | 53 |
| Compass Therapeutics | 39 |
| Inhibikase Therapeutics | 35 |
PALI News
- 3 days ago - Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis - GlobeNewsWire
- 22 days ago - Palisade Bio Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 22 days ago - Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 - GlobeNewsWire
- 4 weeks ago - Palisade Bio initiated with an Outperform at Wolfe Research - TheFly
- 4 weeks ago - Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Palisade Bio reaction to PALI-2108 data ‘looks misaligned’, says Clear Street - TheFly
- 5 weeks ago - Palisade Bio Transcript: Study result - Transcripts
- 5 weeks ago - Palisade Bio announces topline data from PALI-2108 trial - TheFly